Filing Details

Accession Number:
0001209191-16-126370
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-07 19:59:21
Reporting Period:
2016-06-03
Filing Date:
2016-06-07
Accepted Time:
2016-06-07 19:59:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654970 L Ronald Shazer C/O Tracon Pharmaceuticals, Inc.
8910 University Center Lane, Ste. 700
San Diego CA 92122
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-06-03 1,003 $7.48 335 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2015.
  2. The Reporting Person acquired 1,338 shares under the 2015 Equity Incentive Plan on April 20, 2016.